Veet Misra
Chief Financial Officer · ASCENTAGE PHARMA GROUP INTERNATIONAL
Individual
- 2026
- Apr 21, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Veet Misra's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- RA CAPITAL MANAGEMENT, L.P. - $117.62M in ARTV purchases and sales in the last 12 months
- SVF Pauling (Cayman) Ltd - $116.40M in RLAY purchases and sales in the last 12 months
- Bain Capital Life Sciences Investors, LLC - $115.00M in HTFL purchases and sales in the last 12 months
- Michael Simanovsky - $110.65M in SNDA purchases and sales in the last 12 months
- Mayukh Sukhatme - $109.13M in ROIV purchases and sales in the last 12 months
- Emily M. Leproust - $101.55M in TWST purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Veet Misra?
Veet Misra is a corporate insider, tracked as Chief Financial Officer of ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Veet Misra last file a Form 4?
The only primary Form 4 on record is dated 21 April 2026.